Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.
Truvian Sciences has raised $74.0M in total funding. The most recent round was Series D. The last funding was announced in July 2024.
Truvian Sciences's investors include General Catalyst, GreatPoint Ventures, 7wire Ventures, Domain Associates, Tao Capital Partners.
Truvian Sciences is headquartered in San Diego, United States.
Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.
Truvian Sciences is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Truvian Sciences — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/truvian-sciences. Accessed November 13, 2026.
VCBacked. (2024). Truvian Sciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/truvian-sciences
{{cite web |title=Truvian Sciences — Funding & Investors |url=https://www.vcbacked.co/company/truvian-sciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Truvian Sciences? Request a listing update